↑↓ navigate open esc close
Spain PLACE contract award · ocds-ted-347285-2024

Spain – Various medicinal products – suministro del medicamento REBLOZYL (principio activo LUSPATERCEPT 25 MG vial polvo

Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €234K to BRISTOL-MYERS SQUIBB, S.A for Construction & Public Works in June 2024 — one of 94 awards this buyer has made, below its typical award size.

12 Jun 2024
Award date
€234K
Contract value
94 Awards
€338K Avg award
Below vs typical

Winning supplier

BRISTOL-MYERS SQUIBB, S.A
65 Awards
21 Buyers
€153M Total won

Contract description

Spain – Various medicinal products – suministro del medicamento REBLOZYL (principio activo LUSPATERCEPT 25 MG vial polvo subcutanea, LUSPATERCEPT 75 MG vial polvo subcutanea) Y ZEPOSIA (principio activo OZANIMOD 0,92 MG capsula oral), con destino Servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria

Premium

Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria

94 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

50 more awards from this buyer · full history & CSV export

Premium

Other wins · BRISTOL-MYERS SQUIBB, S.A

65 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and BRISTOL-MYERS SQUIBB, S.A — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up